[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370592-105":59,"doc-detail-370592-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-sensitive-genes-for-cervical-cancer-two-sample-mendelian-randomization-with-experimental-validation","The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation","","Study targets novel therapeutic genes for cervical cancer amid limitations from drug resistance and few treatment options. Differentially expressed genes were identified from GEO datasets, followed by two-sample Mendelian randomization to infer causal gene–cancer links. Enrichment analysis and Cancer Genome Atlas validation supported distinct expression patterns. Functional experiments in cervical cancer cells assessed selected targets, including MERTK and SERPINF1, integrating GSEA, drug sensitivity, and prognostic analyses. Results highlight immune microenvironment and survival effects and suggest SERPINF1 restoration and MERTK inhibition.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-sensitive-genes-for-cervical-cancer-two-sample-mendelian-randomization-with-experimental-validation/370592/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-sensitive-genes-for-cervical-cancer-two-sample-mendelian-randomization-with-experimental-validation/370592.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in cervical cancer research?","Question",{"text":112,"@type":113},"It addresses the need for novel therapeutic targets due to treatment limitations caused by drug resistance and a shortage of effective options.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were causal gene–cancer relationships identified?",{"text":117,"@type":113},"The study used two-sample Mendelian randomization after identifying differentially expressed genes from GEO gene-expression datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes received experimental and clinical attention, and what roles were suggested?",{"text":121,"@type":113},"MERTK and SERPINF1 were examined; results suggest roles in tumor growth, spread, invasion, immune infiltration, chromosomal activity, and prognostic outcomes, with potential drug sensitivity effects including paclitaxel.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370592,1790869424,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Women’s Health  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nThe Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation  \nRong Zhang 1–4 , *, Shengjun Chai 1–4 , *, Qihang Chen 1–5 , Jiaming Lai 1–4 , 6 , Chunmei Cai 1–4  \n1Research Center for High Altitude Medicine, Qinghai University Medical College, Xining, Qinghai, People’s Republic of China; 2Key Laboratory of the Ministry of High Altitude Medicine, Qinghai University Medical College, Xining, Qinghai, People’s Republic of China; 3Key Laboratory of Applied Fundamentals of High Altitude Medicine,(Qinghai-Utah Joint Key Laboratory of Plateau Medicine), Qinghai University Medical College, Xining, Qinghai, People’s Republic of China; 4Laboratory for High Altitude Medicine of Qinghai Province, Qinghai University Medical College, Xining, Qinghai, People’s Republic of China; 5Department of Biotechnology, College of Ecological and Environmental Engineering, Qinghai University, Xining, People’s Republic of China; 6Physical Engineering Department, The Fifth People’s Hospital of Qinghai Provincial (Provincial Cancer Hospital), Xining, Qinghai, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Chunmei Cai, Email [caicm@qhu.edu.cn](caicm@qhu.edu.cn)  \n\n| Background: Cervical cancer, the fourth leading cause of female cancer mortality globally, faces treatment limitations due to drug resistance and few therapeutic options. This study seeks to identify novel therapeutic targets to address this urgent clinical need. Methods: Our team identified differentially expressed genes (DEGs) in cervical cancer using gene expression omnibus (GEO) datasets. Subsequently, Mendelian randomization (MR) analysis identified causal gene–cancer relationships, followed by enrichment analysis and The Cancer Genome Atlas (TCGA) validation. Finally, we further validated the functions of the selected target genes in cervical cancer cells and analyzed their Gene Set Enrichment Analysis (GSEA) results, drug sensitivity, and prognostic value. Results: We identified 2,801 upregulated and 1,646 downregulated DEGs. MR analysis identified 21 key cervical cancer-associated genes (14 upregulated, 7 downregulated), with TCGA validation confirming significant differential expression patterns. Among them, few studies have examined these core genes, particularly MERTK and SERPINF1, in cervical cancer. Experiments showed that MERTK and SERPINF1 playa role in cervical cancer. These genes help cancer cells grow, spread, and invade surrounding tissue. Mechanistically, MERTK regulates immune infiltration, whereas SERPINF1 modulates chromosomal activity. Clinically, SERPINF1 enhances overall survival (OS), diseasespecific survival (DSS), and progression-free interval (PFI) in individuals with cervical cancer. Moreover, we discovered that several commonly used drugs for cervical cancer treatment, like paclitaxel, showed high efficacy against MERTK and SERPINF1.\u003Cbr>Conclusion: Our study uncovers MERTK and SERPINF1 as critical regulators of cervical cancer progression and survival, offering mechanistic insights into their roles in tumor behavior and the immune microenvironment. These findings provide a foundation for precision therapies, with SERPINF1 restoration and MERTK inhibition as promising strategies. Clinical translation of these targets could address current treatment limitations.\u003Cbr>Keywords: Mendelian randomization, cervical cancer, MERTK, SERPINF1, experimental validation |\n| --- |\n| Introduction\u003Cbr>According to GLOBOCAN data, there were approximately 661,021 new cervical cancer cases worldwide (the agestandardized rate (ASR): 14. 1%) and 348,189 deaths (ASR: 7. 1%) in recent years.1,2 Low-income countries showed higher rates than high-income nations (19 .3 vs 12.1 per 100,000 incidence; 12.4 vs 4.8 mortality) .1 Between 1990 and 2021, cases increased 62.9%(400,000 to 600,000), while deaths rose 40.2%(","cbCaiaqKcKV84h9V","https://ap.wps.com/l/cbCaiaqKcKV84h9V","pdf",15923167,22,"English","# Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and screening\n## Treatment challenges and subtypes","[{\"question\":\"What problem does the study address in cervical cancer research?\",\"answer\":\"It addresses the need for novel therapeutic targets due to treatment limitations caused by drug resistance and a shortage of effective options.\"},{\"question\":\"How were causal gene–cancer relationships identified?\",\"answer\":\"The study used two-sample Mendelian randomization after identifying differentially expressed genes from GEO gene-expression datasets.\"},{\"question\":\"Which genes received experimental and clinical attention, and what roles were suggested?\",\"answer\":\"MERTK and SERPINF1 were examined; results suggest roles in tumor growth, spread, invasion, immune infiltration, chromosomal activity, and prognostic outcomes, with potential drug sensitivity effects including paclitaxel.\"}]","The Sensitive Genes for Cervical Cancer: Two-Sample Mendelian Randomization with Experimental Validation | PDF",1790189382,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e48caa48b5328a3c8223a583c0f14c45.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/171c1c09562997fe5f78fe7e28c20c34.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1acec3cc981b9baf0521cf868473d62.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bd52796249b5662d2b8329aedbd9536.webp",980,1268]